The SURMOUNT-4 trial showed that 82.5% of participants who stopped tirzepatide regained at least 25% of their lost weight within one year
doi: 10.1016/j.ejps.2025.107073 Summary Keywords hepatoprotection, hepatotoxicity, morin, nano-formulations, oxidative stress, synergistic therapy Citation Sivalingam AM (2026) Crosstalk along the gut-liver axis modulates glutathione and cadmium-induced hepatotoxicity
Although data remain limited, several studies suggest a correlation between T2DM and impaired semen quality
FDA approves Lilly's Zepbound (tirzepatide) for chronic weight management owenhaskins Nov 8, 2023 4 min read Updated: Nov 9, 2023 The FDA has approved Eli Lilly and Company's Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors
Ultrasound is preferred for younger patients and is excellent for differentiating cysts from solid masses
A small protein-rich meal 30 to 60 minutes before your injection can significantly reduce nausea compared to injecting on an empty stomach
